MUSSINI, Cristina
 Distribuzione geografica
Continente #
NA - Nord America 54.832
EU - Europa 28.242
AS - Asia 23.925
SA - Sud America 4.166
AF - Africa 580
OC - Oceania 104
Continente sconosciuto - Info sul continente non disponibili 33
AN - Antartide 1
Totale 111.883
Nazione #
US - Stati Uniti d'America 53.948
GB - Regno Unito 9.249
SG - Singapore 7.891
IT - Italia 7.434
CN - Cina 7.028
HK - Hong Kong 3.827
BR - Brasile 3.333
DE - Germania 2.465
SE - Svezia 2.427
VN - Vietnam 1.555
RU - Federazione Russa 1.378
FI - Finlandia 992
FR - Francia 821
UA - Ucraina 740
ID - Indonesia 672
TR - Turchia 614
KR - Corea 560
CA - Canada 524
NL - Olanda 507
BG - Bulgaria 493
IN - India 438
AR - Argentina 352
ES - Italia 243
MX - Messico 233
ZA - Sudafrica 232
BD - Bangladesh 190
JP - Giappone 186
AT - Austria 181
LT - Lituania 175
IR - Iran 166
PL - Polonia 166
IE - Irlanda 162
BE - Belgio 144
EC - Ecuador 140
SI - Slovenia 135
IQ - Iraq 117
CH - Svizzera 102
MY - Malesia 94
CO - Colombia 92
AU - Australia 90
RO - Romania 84
PK - Pakistan 83
CZ - Repubblica Ceca 76
MA - Marocco 72
CL - Cile 65
AE - Emirati Arabi Uniti 56
PY - Paraguay 56
IL - Israele 43
PE - Perù 43
SA - Arabia Saudita 42
UZ - Uzbekistan 42
VE - Venezuela 41
EG - Egitto 40
JO - Giordania 40
TH - Thailandia 37
KE - Kenya 33
PH - Filippine 33
GR - Grecia 32
NO - Norvegia 32
RS - Serbia 30
EE - Estonia 29
AZ - Azerbaigian 28
DO - Repubblica Dominicana 26
UY - Uruguay 25
EU - Europa 24
UG - Uganda 24
KZ - Kazakistan 23
NP - Nepal 23
TN - Tunisia 22
TW - Taiwan 22
BZ - Belize 21
ET - Etiopia 21
DZ - Algeria 20
AL - Albania 18
PA - Panama 18
KG - Kirghizistan 17
MK - Macedonia 16
DK - Danimarca 15
PT - Portogallo 15
NZ - Nuova Zelanda 14
SN - Senegal 14
BO - Bolivia 13
OM - Oman 13
SK - Slovacchia (Repubblica Slovacca) 13
CR - Costa Rica 11
JM - Giamaica 11
LV - Lettonia 11
BA - Bosnia-Erzegovina 10
NG - Nigeria 10
TZ - Tanzania 10
GE - Georgia 9
HU - Ungheria 9
KW - Kuwait 9
LB - Libano 9
GA - Gabon 8
HR - Croazia 8
LK - Sri Lanka 8
MD - Moldavia 8
A2 - ???statistics.table.value.countryCode.A2??? 7
BY - Bielorussia 7
Totale 111.695
Città #
Southend 6.586
Fairfield 6.140
Santa Clara 5.744
Singapore 5.370
Ashburn 5.323
Hong Kong 3.773
Woodbridge 3.406
Chandler 3.320
Houston 2.673
Seattle 2.404
Hefei 2.336
Wilmington 2.087
Cambridge 2.065
London 1.638
Nyköping 1.527
Ann Arbor 1.338
Jacksonville 1.297
Dearborn 1.228
Beijing 1.158
Los Angeles 974
Modena 920
Chicago 862
New York 783
San Diego 741
Helsinki 594
Dallas 568
Jakarta 566
Princeton 547
Munich 537
Seoul 525
Milan 522
Ho Chi Minh City 521
Rome 497
Sofia 483
Moscow 414
Shanghai 390
The Dalles 353
Bologna 339
Buffalo 339
Izmir 327
Salt Lake City 327
São Paulo 313
Hanoi 295
Eugene 276
Bremen 260
Council Bluffs 217
Frankfurt am Main 214
Redwood City 186
Nuremberg 177
Tampa 160
Boardman 159
Toronto 153
Turku 145
Amsterdam 144
Dublin 143
Redondo Beach 143
Tokyo 143
Fremont 141
Naples 135
Brussels 132
Elk Grove Village 132
Warsaw 127
Montreal 126
Phoenix 126
Des Moines 121
Brooklyn 111
Atlanta 109
Johannesburg 107
Rio de Janeiro 107
Columbus 106
Kent 106
Parma 106
Florence 103
Mexico City 99
Guangzhou 98
Falls Church 96
Lauterbourg 95
Falkenstein 92
Orem 91
Dong Ket 89
San Jose 89
Stockholm 89
Chennai 88
Denver 88
Norwalk 83
Paris 82
Vienna 82
Turin 73
Sterling 72
Nanjing 71
Boston 70
Haiphong 70
San Francisco 70
Lappeenranta 67
Ottawa 66
Palermo 66
Reggio Emilia 66
Madrid 65
Bari 64
Lancaster 64
Totale 78.710
Nome #
Un raro caso di prostatite da Candida albicans, Candida krusei ed Enterococcus fecium 1.554
Late presentation increases risk and costs of non-infectious comorbidities in people with HIV: An Italian cost impact study 782
Multidrug-resistant tuberculosis outbreak in an Italian prison: Tolerance of pyrazinamide plus levofloxacin prophylaxis and serial interferon gamma release assays 741
Comparative evaluation of subtyping tools for surveillance of newly emerging HIV-1 strains 673
Recommendations for the use of hepatitis C virus protease inhibitors for the treatment of chronic hepatitis C in HIV-infected persons. A position paper of the Italian Association for the Study of Infectious and Tropical Disease 599
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy 572
Migration and health: A retrospective study about the prevalence of HBV, HIV, HCV, tuberculosis and syphilis infections amongst newly arrived migrants screened at the Infectious Diseases Unit of Modena, Italy 565
Granulicatella adiacens and Abiotrophia defectiva Native Vertebral Osteomyelitis: Three Cases and Literature Review of Clinical Characteristics and Treatment Approach 555
COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion 464
Ceftazidime-avibactam use for KPC-Kp infections: a retrospective observational multicenter study 456
Acinetobacter baumannii Resistance to Sulbactam/Durlobactam: A Systematic Review 441
A frailty index predicts survival and incident multimorbidity independent of markers of HIV disease severity 405
Clinical Utility of Epstein-Barr Virus Viral Load Monitoring and Risk Factors for Posttransplant Lymphoproliferative Disorders After Kidney Transplantation 403
A five-component infection control bundle to permanently eliminate a carbapenem-resistant Acinetobacter baumannii spreading in an intensive care unit 400
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 393
Efficient T cell compartment in HIV+ patients receiving orthotopic liver transplant and immunosuppressive therapy 386
T cell activation but not polyfunctionality after primary HIV infection predicts control of viral load and length of the time without therapy. 381
Clinical outcome of kidney transplantation in HIV-infected recipients: a retrospective study 377
Handling and processing of blood specimens from patients with Covid-19 for safe studies on cell phenotype and cytokine storm 363
Identification and characterization of an aspartyl protease from Cryptococcus neoformans 362
A frailty index predicts post-liver transplant morbidity and mortality in HIV-positive patients 356
Analysis of inflammasomes and antiviral sensing components reveals decreased expression of NLRX1 in HIV-positive patients assuming efficient antiretroviral therapy 356
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with Covid-19 pneumonia. 350
NK-cell phenotype at interruption underlies widely divergent duration of CD4+-guided antiretroviral treatment interruption. 348
Aging with HIV infection: a journey to the center of inflammAIDS, immunosenescence and neuroHIV 347
Performance of tests for latent tuberculosis in different groups of immunocompromised patients 341
T cell homeostasis in centenarians: from the thymus to the periphery. 340
Successful treatment of HIV-1 infection increases the expression of a novel, short transcript for IL-18 receptor α chain 339
MDR1 C3435T genetic polymorphism does not influence the response to antiretroviral therapy in drug-naive HIV-positive patients 336
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study 336
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study 333
Gastric Mucormycosis in a Liver and Kidney Transplant Recipient: Case Report and Concise Review of Literature 331
Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID-19 pneumonia 328
Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study 327
Inverse correlation between vascular calcification and bone mineral density in human immunodeficiency virus-infected patients 326
Ageing and inflammation in patients with HIV infection 320
Exploring viral reservoir: The combining approach of cell sorting and droplet digital PCR 319
Aging with HIV vs. HIV Seroconversion at Older Age: A Diverse Population with Distinct Comorbidity Profiles 314
Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia - challenges, strengths, and opportunities in a global health emergency. 311
Absence of liver steatosis in HIV-HCV co-infected patients receiving regimens containing tenofovir or abacavir 309
Antimicrobial stewardship in a Gastroenterology Department: Impact on antimicrobial consumption, antimicrobial resistance and clinical outcome 309
The human immunodeficiency virus (HIV) protease inhibitor indinavir directly affects the opportunistic fungal pathogen Cryptococcus neoformans 308
Th1 and Th17 pro-inflammatory profile characterizes iNKT cells in virologically suppressed HIV+ patients with low CD4/CD8 ratio 306
Decay pattern of anti–SARS–CoV–2 antibodies in PWH 305
Acute human herpes virus 7 (HHV-7) encephalitis in an immunocompetent adult patient: a case report and review of literature 305
Acute myeloid leukemia in patients living with HIV infection: Several questions, fewer answers 305
Herpes Simplex re-activation in patients with SARS-CoV2 pneumonia: a prospective observational study. 305
Increased plasma levels of extracellular mitochondrial DNA during HIV infection: a new role for mitochondrial damage-associated molecular patterns during inflammation. 303
Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality. 301
Rhodococcus equi Pneumonia in Kidney Transplant Recipient Affected by Acute Intermittent Porphyria: A Case Report 300
Machine learning algorithm to predict weight change in ART experienced PWH 298
Voice assistance to develop a participatory research and action to improve health trajectories of people with PACS 296
HIV-1 Infection and the Aging of the Immune System: Facts, Similarities and Perspectives 295
Impact of polypharmacy on antiretroviral prescription in people living with HIV. 294
Gram-positive bloodstream infections in liver transplant recipients: incidence, risk factors, and impact on survival. 291
Cytometry, immunology, and HIV infection: Three decades of strong interactions. 290
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 289
Re: Lebentrau S, Gilfrich C, Vetterlein MW, Schumacher H, Spachmann PJ, Brookman-May SD, Fritsche HM, Schostak M, Wagenlehner F, Burger M, May M, MR2 study group (2017) Impact of the medical specialty on knowledge regarding multidrug-resistant organisms and strategies toward antimicrobial stewardship. Int Urol Nephrol 49:1311–1318 289
Apoptotic features of peripheral blood granulocytes and monocytes during primary, acute HIV infection. 285
Mucorales-specific T cells in patients with hematologic malignancies 285
Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy. 284
Calendar time trends in the incidence and prevalence of triple-class virologic failure in antiretroviral drug-experienced people with HIV in Europe. 284
Intact parathyroid hormone levels are associated with increased carotid intima media thickness in HIV infected patients 283
Evaluation of serum (1 → 3)-β-D-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors 283
Tenofovir accelerates bone mass loss of the lumbar spine in the first years of menopause in HIV infected women 282
CD4+ T-cell differentiation, regulatory T cells and gag-specific T lymphocytes are unaffected by CD4-guided treatment interruption and therapy resumption. 282
Altered Expression of PYCARD, Interleukin 1β, Interleukin 18, and NAIP in Successfully Treated HIV-Positive Patients With a Low Ratio of CD4+ to CD8+ T Cells 282
Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes 281
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 281
First and second wave among hospitalized COVID-19 patients with severe pneumonia: a comparison of 28-day mortality over 1-year pandemic in a tertiary university hospital in Italy. 281
HIV-DNA content in different CD4+ T-cell subsets correlates with CD4+ cell : CD8+ cell ratio or length of efficient treatment 280
Effect of treatment interruption monitored by CD4 cell count on mitochondrial DNA content in HIV-infected patients: a prospective study 278
Mitochondrial DNA Haplogroups and Highly Active Antiretroviral Therapy–Related Lipodystrophy 278
Transmitted HIV Type 1 drug resistance and Non-B subtypes prevalence among seroconverters and newly diagnosed patients from 1992 to 2005 in Italy. 278
Lower Frailty Is Associated with Successful Cognitive Aging Among Older Adults with HIV 278
Immunophenotypic Profile and Clinical Outcome of Monoclonal B-cell Lymphocytosis in Kidney Transplantation 278
RAAS inhibitors are not associated with mortality in COVID-19 patients: findings from an observational multicenter study in Italy and a meta-analysis of 19 studies 278
Changes in central adipose tissue after switching to integrase inhibitors 278
Predictive Value of Intracellular HIV-1 DNA Levels During CD4-Guided Treatment Interruption in HIV(+) Patients 277
Cytotoxic granule release dominates gag-specific CD4+ T-cell response in different phases of HIV infection. 277
Novel genetic association of TNF-α-238 and PDCD1-7209 polymorphisms with long-term non-progressive HIV-1 infection. 277
Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator. 277
Correlates of frailty phenotype and frailty index and their associations with clinical outcomes 276
Expansion of plasmablasts and loss of memory B cells in peripheral blood from COVID-19 patients with pneumonia 276
Monocyte Distribution Width (MDW) as novel inflammatory marker with prognostic significance in COVID-19 patients 270
Upregulation of nuclear-encoded mitochondrial LON protease in HAART-treated HIV-positive patients with lipodystrophy: implications for the pathogenesis of the disease 268
Hypokalemia in Patients with COVID-19 268
Refining criteria for selecting candidates for a safe lopinavir/ritonavir or darunavir/ritonavir monotherapy in HIV-infected virologically suppressed patients 267
Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis. 265
The protease inhibitor atazanavir triggers autophagy and mitophagy in human preadipocytes 265
Non–alcoholic to metabolic associated fatty liver disease: cardiovascular implications of a change in terminology in patients living with HIV 264
The natural history of HIV-associated lipodystrophy in the changing scenario of HIV infection 263
Impact of Pre-Analytical Time on the Recovery of Pathogens from Blood Cultures: Results from a Large Retrospective Survey 263
Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital 261
Molecular Imaging of Vascular Calcification with 18 F-Sodium-Fluoride in Patients Infected with Human Immunodeficiency Virus 260
Circulating Mitochondrial DNA and Lipopolysaccharide-Binding Protein but Not Bacterial DNA Are Increased in Acute Human Immunodeficiency Virus Infection. 260
Different sensitivity to apoptosis in cells of monocytic or lymphocytic origin chronically infected with human immunodeficiency virus type-1 259
Incidence of HCV infection amongst HIV positive men who had sex with men and prevalence data from patients followed at the Infectious Diseases Clinic of Modena, Italy 259
The pathway of NAFLD vs MAFLD toward significant fibrosis 258
Clinical and Microbiological Characteristics of Visceral Leishmaniasis Outbreak in a Northern Italian Nonendemic Area: A Retrospective Observational Study 258
Totale 34.415
Categoria #
all - tutte 504.614
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 504.614


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218.867 0 0 0 0 0 1.795 1.340 1.557 865 1.343 1.171 796
2021/202210.634 777 1.030 792 554 405 713 642 588 1.211 850 1.800 1.272
2022/202310.959 1.236 1.234 906 965 1.235 1.341 331 1.062 1.203 222 573 651
2023/20248.748 363 588 619 844 1.450 790 703 1.129 330 282 531 1.119
2024/202524.714 804 410 453 1.816 4.071 3.767 1.679 1.555 2.970 1.747 2.407 3.035
2025/202624.298 3.210 2.040 4.312 6.024 6.922 1.790 0 0 0 0 0 0
Totale 112.917